Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥187.71 Million ≈ $27.47 Million USD) by net assets (CN¥3.27 Billion ≈ $478.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Beijing New Oriental Star Petrochemical (002755) market capitalisation for the company's overall valuation and market capitalisation.
Beijing New Oriental Star Petrochemical Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their cash flow conversion efficiency. Explore Beijing New Oriental Star Petrochemical (002755) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Black Box Limited
NSE:BBOX
|
0.059x |
|
Montea C.V.A.
BR:MONT
|
0.018x |
|
Jiangsu Zhangjiagang Rural Commercial Bank Co Ltd
SHE:002839
|
0.253x |
|
Airport City Ltd
TA:ARPT
|
0.013x |
|
V-Guard Industries Limited
NSE:VGUARD
|
0.082x |
|
Systex Corp
TW:6214
|
0.254x |
|
Dongguan Development Holdings Co Ltd
SHE:000828
|
0.081x |
|
Metrics Master Income Trust
AU:MXT
|
0.036x |
Annual Cash Flow Conversion Efficiency for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024. View 002755 live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.14 Billion ≈ $459.81 Million |
CN¥411.36 Million ≈ $60.19 Million |
0.131x | +1583.47% |
| 2023-12-31 | CN¥3.01 Billion ≈ $440.56 Million |
CN¥-26.57 Million ≈ $-3.89 Million |
-0.009x | +49.65% |
| 2022-12-31 | CN¥3.01 Billion ≈ $440.95 Million |
CN¥-52.81 Million ≈ $-7.73 Million |
-0.018x | -109.96% |
| 2021-12-31 | CN¥3.23 Billion ≈ $472.29 Million |
CN¥567.71 Million ≈ $83.07 Million |
0.176x | -8.07% |
| 2020-12-31 | CN¥3.03 Billion ≈ $443.85 Million |
CN¥580.38 Million ≈ $84.93 Million |
0.191x | -9.93% |
| 2019-12-31 | CN¥2.52 Billion ≈ $368.25 Million |
CN¥534.62 Million ≈ $78.23 Million |
0.212x | -21.33% |
| 2018-12-31 | CN¥1.84 Billion ≈ $269.39 Million |
CN¥497.16 Million ≈ $72.75 Million |
0.270x | +414.08% |
| 2017-12-31 | CN¥585.03 Million ≈ $85.61 Million |
CN¥-50.30 Million ≈ $-7.36 Million |
-0.086x | -361.81% |
| 2016-12-31 | CN¥509.40 Million ≈ $74.54 Million |
CN¥16.73 Million ≈ $2.45 Million |
0.033x | +2179.89% |
| 2015-12-31 | CN¥508.35 Million ≈ $74.39 Million |
CN¥-802.68K ≈ $-117.46K |
-0.002x | +98.51% |
| 2014-12-31 | CN¥333.61 Million ≈ $48.82 Million |
CN¥-35.30 Million ≈ $-5.17 Million |
-0.106x | -143.79% |
| 2013-12-31 | CN¥307.51 Million ≈ $45.00 Million |
CN¥-13.35 Million ≈ $-1.95 Million |
-0.043x | -110.74% |
| 2012-12-31 | CN¥263.39 Million ≈ $38.54 Million |
CN¥106.47 Million ≈ $15.58 Million |
0.404x | +160.84% |
| 2011-12-31 | CN¥214.83 Million ≈ $31.44 Million |
CN¥33.29 Million ≈ $4.87 Million |
0.155x | -- |
About Beijing New Oriental Star Petrochemical Engineering Co Ltd
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more